- Home
- ORGO vs ABL Comparison
ORGO vs ABL Comparison
Compare ORGO & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ABL
- Stock Information
- Founded
- ORGO 1985
- ABL 2004
- Country
- ORGO United States
- ABL United States
- Employees
- ORGO N/A
- ABL N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ABL Investment Managers
- Sector
- ORGO Health Care
- ABL Finance
- Exchange
- ORGO Nasdaq
- ABL Nasdaq
- Market Cap
- ORGO 665.8M
- ABL 714.2M
- IPO Year
- ORGO N/A
- ABL N/A
- Fundamental
- Price
- ORGO $4.28
- ABL $7.33
- Analyst Decision
- ORGO Buy
- ABL Strong Buy
- Analyst Count
- ORGO 2
- ABL 4
- Target Price
- ORGO $5.50
- ABL $13.88
- AVG Volume (30 Days)
- ORGO 1.3M
- ABL 286.2K
- Earning Date
- ORGO 05-08-2025
- ABL 03-27-2025
- Dividend Yield
- ORGO N/A
- ABL N/A
- EPS Growth
- ORGO N/A
- ABL N/A
- EPS
- ORGO N/A
- ABL N/A
- Revenue
- ORGO $482,043,000.00
- ABL $111,923,786.00
- Revenue This Year
- ORGO N/A
- ABL $64.51
- Revenue Next Year
- ORGO $7.62
- ABL $67.47
- P/E Ratio
- ORGO N/A
- ABL N/A
- Revenue Growth
- ORGO 11.29
- ABL 68.56
- 52 Week Low
- ORGO $2.17
- ABL $6.75
- 52 Week High
- ORGO $6.71
- ABL $12.50
- Technical
- Relative Strength Index (RSI)
- ORGO 43.72
- ABL 46.01
- Support Level
- ORGO $4.80
- ABL $7.20
- Resistance Level
- ORGO $5.57
- ABL $8.70
- Average True Range (ATR)
- ORGO 0.32
- ABL 0.49
- MACD
- ORGO -0.15
- ABL -0.01
- Stochastic Oscillator
- ORGO 3.73
- ABL 15.85
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ABL Abacus Life Inc.
Abacus Global Management Inc, formerly Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.